Dexcom Thrives Amid Weight Loss Drug Race episode artwork

EPISODE · Apr 23, 2026 · 1 MIN

Dexcom Thrives Amid Weight Loss Drug Race

from The Daily News Now! Business

Dexcom, a continuous glucose monitor specialist, is poised for growth amidst the weight loss boom, despite risks associated with competitors like Eli Lilly and Novo Nordisk. Contrary to initial concerns, GLP-one drugs have actually increased CGM usage. Dexcoms strategic positioning, with over-the-counter options and a network of compatible devices, sets it apart from pharma giants, ensuring steady gains as it taps into the vast, underserved CGM market. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/ac11c73d5757ffbc

NOW PLAYING

Dexcom Thrives Amid Weight Loss Drug Race

0:00 1:23

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Daily News Now! Business?

This episode is 1 minute long.

When was this The Daily News Now! Business episode published?

This episode was published on April 23, 2026.

What is this episode about?

Dexcom, a continuous glucose monitor specialist, is poised for growth amidst the weight loss boom, despite risks associated with competitors like Eli Lilly and Novo Nordisk. Contrary to initial concerns, GLP-one drugs have actually increased...

Can I download this The Daily News Now! Business episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!